Emgality 'inactive' but Lilly still working on listing

June 2, 2020 Latest News

This is a preview of subscriber content

Subscribe now to continue reading.

Industry sources told BioPharmaDispatch 'inactivating' PBAC recommendations could be part of a wider politically-driven move to clearly shift responsibility for the non-implementation of outcomes to companies. …

Subscribe now to continue reading.

Latest Video

New combination therapy sets landmark survival benchmark in bladder cancer treatment
October 19, 2025 - Latest News
Merck expands commitment to first nations STEM leadership with new scholarships and partnerships
October 19, 2025 - Latest News
'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'
October 21, 2025 - Latest News
Australia records worst flu season on record as vaccination rates stagnate
October 20, 2025 - Latest News
NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter
October 20, 2025 - Latest News

Emgality 'inactive' but Lilly still working on listing

This is a preview of subscriber content

Latest Video

Most Read

New combination therapy sets landmark survival benchmark in bladder cancer treatment

Merck expands commitment to first nations STEM leadership with new scholarships and partnerships

'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'

Australia records worst flu season on record as vaccination rates stagnate

NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter

New Stories

IDT Australia sharpens strategy with cost savings and radiopharmaceutical focus

FOI reforms set back transparency decades and will impact public health decision-making

Astellas' XTANDI achieves landmark survival milestone in prostate cancer

Services Australia reports record number of processed PBS prescriptions

Endometriosis diagnoses in Australian GP clinics nearly double over a decade

'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'

Vaccine confidence slips as Australians grow more concerned about access to healthcare

Sign In

Emgality 'inactive' but Lilly still working on listing

This is a preview of subscriber content

Latest Video

Most Read

New combination therapy sets landmark survival benchmark in bladder cancer treatment

Merck expands commitment to first nations STEM leadership with new scholarships and partnerships

'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'

Australia records worst flu season on record as vaccination rates stagnate

NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter

Follow Us

New Stories

IDT Australia sharpens strategy with cost savings and radiopharmaceutical focus

FOI reforms set back transparency decades and will impact public health decision-making

Astellas' XTANDI achieves landmark survival milestone in prostate cancer

Services Australia reports record number of processed PBS prescriptions

Endometriosis diagnoses in Australian GP clinics nearly double over a decade

'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'

Vaccine confidence slips as Australians grow more concerned about access to healthcare